<DOC>
	<DOCNO>NCT00496535</DOCNO>
	<brief_summary>The primary objective first phase determine safety , maximum tolerate dose ( MTD ) dose-limiting toxicity TNFerade combination previously study combination Fluorouracil ( 5FU ) , Hydroxyurea ( HU ) standard daily radiotherapy patient recurrent head neck cancer ( RHNC ) . All chemoradiotherapy administer `` week-on/week-off '' schedule . The primary objective second phase II determine locoregional control rate 24 month .</brief_summary>
	<brief_title>A Study TNFeradeâ„¢ Biologic With Concomitant Radiotherapy , Fluorouracil , Hydroxyurea ( TNF-FHX ) Patients With Head Neck Cancer</brief_title>
	<detailed_description />
	<mesh_term>Head Neck Neoplasms</mesh_term>
	<mesh_term>Fluorouracil</mesh_term>
	<mesh_term>Hydroxyurea</mesh_term>
	<criteria>Head neck cancer Patients must locoregional tumor amenable reirradiation curative intent . disease , majority disease , accessible injection via direct intratumoral injection Life expectancy great 12 week Age &gt; 18 year ECOG performance status 01 Metastatic disease History malignancy ( head neck cancer ) last 2 year except carcinoma situ cervix bladder , nonmelanomatous skin cancer , localize early stage prostate cancer , patient continually disease free , cancer felt influence treatment head neck cancer life expectancy patient Patients may receive investigational agent currently within 4 week prior study Day 1 Active infection type Chronic treatment great 6 month steroid Pregnant lactate woman Patients known history cerebral vascular disease ; stroke TIA within last 6 month Patients history document thrombosis ( PE DVT ) , know coagulopathy thrombophilia , evidence DVT / thromboembolic event upon enrollment Patients receive hormone replacement therapy hormonal contraceptive within two week day 1 Patients undergone surgery within last 1 month prior day 1 Patients active carotid artery involvement status post carotid artery graft / stenting</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2011</verification_date>
	<keyword>head</keyword>
	<keyword>neck</keyword>
	<keyword>cancer</keyword>
	<keyword>neoplasm</keyword>
</DOC>